The International Society for Pharmaceutical Engineering (ISPE) is to release its Drug Shortages Prevention Plan at its annual meeting in Las Vegas.
The ISPE Drug Shortages Task Team developed the plan as part of its initiative launched in response to a European Medicines Agency request for a collaborative action plan developed to stop drug shortages due to manufacturing and quality issues.
The ISPE’s plan lays out how the industry can effectively prevent drug shortages from occurring by identifying the causes of supply disruptions and creating a culture of quality that ensures robust, resilient and reliable medication supply.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze